Login to Your Account

Stem Cell Firm ReNeuron Seeks $15M in Discounted Offering

By Cormac Sheridan
Staff Writer

Wednesday, April 4, 2012
Shares in ReNeuron plc dropped 16 percent Tuesday on news that the stem cell therapy developer is seeking up to £9.4 million (US$14.6 million) in new funding through a combined share placing and open offer.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription